DaVita Inc (DVA)

73.09 -0.65  -0.88% NYSE Mar 27, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/07/2020 17:00 EDT Misc DaVita Inc First Quarter Earnings Conference Call in 2020
05/07/2020 Earnings DaVita Inc First Quarter Earnings in 2020 Release
02/21/2020 Misc DaVita Inc Annual Report for 2019
02/10/2020 17:00 EST Misc DaVita Inc Fourth Quarter Earnings Conference Call for 2019
02/10/2020 Earnings DaVita Inc Fourth Quarter Earnings in 2019 Release
11/05/2019 17:00 EST Misc DaVita Inc Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings DaVita Inc Third Quarter Earnings in 2019 Release
08/01/2019 17:00 EDT Misc DaVita Inc Second Quarter Earnings Conference Call in 2019
08/01/2019 Earnings DaVita Inc Second Quarter Earnings in 2019 Release
06/17/2019 10:00 MDT Misc DaVita Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.davita.com
  • Investor Relations URL: http://investors.davita.com/phoenix.zhtml?c=76556&p=irol-irHome
  • HQ State/Province: Colorado
  • Sector: Healthcare
  • Industry: Medical Care Facilities
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: May. 07, 2020
  • Last Earnings Release: Feb. 10, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates about 3,000 facilities worldwide, mostly in the U.S., and treats over 235,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Top Fund Holders

Symbol Name Weighting
CHO104 Chou Associates Class F 3.44%
THORX Thornburg Global Opportunities R3 3.40%
TCGRX Thornburg Core Growth R4 3.19%
XHS SPDR® S&P Health Care Services ETF 3.10%
FOUSA06MSX JNL/S&P Total Yield A 2.42%
FOUSA06MSW JNL/S&P Intrinsic Value A 2.35%
ZUH.TO BMO Eq Wght US HlthCare Hdgd to CAD ETF 2.01%
MIDUX DWS ESG Core Equity R6 2.01%
RYH Invesco S&P 500® Equal Wt Hlth Care ETF 1.97%
IHF iShares US Healthcare Providers ETF 1.92%
FTHI First Trust BuyWrite Income ETF 1.79%
VUSE Vident Core US Equity 0.64%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.